Enhanced Immunogenicity of Engineered HER2 Antigens Potentiates Antitumor Immune Responses.
Jeon I, Lee JM, Shin KS, Kang T, Park MH, Seo H, Song B, Koh CH, Choi J, Shin YK, Kim BS, Kang CY.
Jeon I, et al. Among authors: park mh.
Vaccines (Basel). 2020 Jul 22;8(3):403. doi: 10.3390/vaccines8030403.
Vaccines (Basel). 2020.
PMID: 32707803
Free PMC article.